Integrating Biomarker Testing, Recent Advances, and Emerging Treatment Approaches into Clinical Pathways for NSCLC
Saturday, October 15, 2022
3:40 PM – 4:25 PM
Learning Objectives:
Describe the role of genetic mutations, current biomarker testing techniques, and guidelines for utilizing biomarker testing in clinical practice
Evaluate the mechanisms, efficacy, safety, and cost effectiveness of current and emerging treatment approaches to optimize clinical pathways for NSCLC
Implement therapeutic strategies that include biomarker and molecular analysis, guideline recommendations, targeted therapy, and emerging treatment approaches to personalize treatment and optimize outcomes and value